BioMotiv is the mission-driven, for-profit therapeutic accelerator affiliated with The Harrington Project for Discovery and Development, a $250 million initiative announced by University Hospitals this past February.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/06/12 | $21,000,000 | Growth |
Harrington Family University Hospitals | undisclosed |
| 08/05/13 | $25,000,000 |
Harrington Family Nationwide Mutual Insurance Company University Hospitals | undisclosed |
